Providence Wealth Advisors, LLC Edwards Lifesciences Corp Transaction History

Providence Wealth Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 10, 2020	SELL	$67.19 - $87.44 $604,508 - $786,697	-8,997 Closed	0 $0
Q2 2020 Aug 07, 2020	BUY	$57.54 - $76.95 $345,124 - $461,546	5,998 Added 200.0%	8,997 $622,000
Q1 2020 May 05, 2020	SELL	$52.41 - $81.0 $26,205 - $40,500	-500 Reduced 14.29%	2,999 $540,000
Q4 2019 Jan 29, 2020	SELL	$71.7 - $82.09 $30,114 - $34,477	-420 Reduced 10.72%	3,499 $812,000
Q2 2019 Jul 22, 2019	BUY	$55.74 - $64.41 $1,950 - $2,254	35 Added 0.9%	3,919 $727,000
Q1 2018 Aug 14, 2018	BUY	$37.19 - $47.45 $144,445 - $184,295	3,884 New	3,884 $526,000

1,351

455M

9.76M

3.92M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Providence Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Providence Wealth Advisors, LLC with notifications on news.